Baylis Medical Technologies

Baylis Medical Technologies

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $105M

Overview

Baylis Medical Technologies is a privately held, commercial-stage medical device company founded in 1986 and headquartered in Mississauga, Canada (with a strong U.S. presence). The company specializes in innovative access solutions for endovascular procedures, with flagship products like the PowerWire® RF guidewire family and Passport® Steerable Sheath. It operates through two divisions: Endovascular (product commercialization) and Design and Manufacturing Services (contract services). With a global commercial footprint and a focus on complex, high-value procedures, Baylis is positioned in the growing market for advanced vascular access and crossing devices.

CardiovascularPeripheral VascularBiliary

Technology Platform

Proprietary radiofrequency (RF) energy and steerable sheath platforms for vascular access and crossing of chronic total occlusions (CTOs) and complex anatomy.

Funding History

2
Total raised:$105M
Series B$75M
Series A$30M

Opportunities

The growing global prevalence of complex peripheral and coronary artery disease, especially chronic total occlusions (CTOs), drives demand for specialized crossing devices.
Expansion into adjacent interventional specialties like biliary and neurovascular procedures offers significant new market opportunities without requiring a fundamental technological shift.

Risk Factors

Intense competition from larger, diversified medical device companies with greater resources poses a market share threat.
Regulatory hurdles and reimbursement challenges across different global markets could delay product launches and limit adoption.
Technological concentration on RF-based crossing carries risk if superior alternative technologies emerge.

Competitive Landscape

Baylis competes in the vascular access and CTO crossing segment against major players like Boston Scientific (CrossBoss, Stingray), Medtronic, and Abbott, as well as specialized firms like Philips (Volcano). Its differentiation lies in its focused RF energy platform for the most challenging occlusions, but it must continually innovate against these well-established competitors.